Abiopharma

General Announcement: Net Asset Value per unit

General Announcement: Net Asset Value per unit

General Announcement: Net Asset Value per unit

General Announcement: Net Asset Value per unit

Clinical trial NCT07630961 updates: 1. start date: 2026-06-15 → 2026-06-23 2. completion date: 2028-01-14 → 2028-01-22 3. primary completion date: 2028-01-14 → 2028-01-22

Clinical trial NCT06347133: primary completion date: 2026-05-01 → 2026-06-01.

Clinical trial NCT06983028: enrollment: 200 → 250 participants.

Clinical trial NCT07559799 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-15 → 2026-06-01 3. completion date: 2029-06-30 → 2029-08-30 4. primary completion date: 2029-06-30 → 2029-08-30

Clinical trial NCT07049653 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-01-31 → 2026-06-04 3. enrollment: 627 → 500 participants

Clinical trial NCT06469190 updates: 1. completion date: 2026-06-20 → 2027-06-20 2. primary completion date: 2025-06-20 → 2026-06-20